Literature DB >> 25299934

The epidemiology of herpes simplex virus eye disease in Northern California.

Tisha Prabriputaloong Stanzel1, Jose D Diaz, Rookaya Mather, Ira G Wong, Todd P Margolis, David C Gritz.   

Abstract

PURPOSE: To calculate the incidence and prevalence of herpes simplex virus (HSV) eye disease in a large, well-defined population in Northern California, USA, and to determine the recurrence rate following an initial episode of disease in this cohort.
METHODS: A retrospective, observational, cohort study using population-based data and medical record review. The patient database of a large, regional health maintenance organization (Northern California Kaiser Permanente) was searched, and the study population consisted of 1,042,351 people over a 1-year study period from 1 July 1998 through 30 June 1999. Only ocular HSV cases with definitive clinical or laboratory confirmed diagnoses were included. Active and inactive cases were included, however only active cases were used in incidence and prevalence calculations. Bilateral disease was counted as one case. Newly diagnosed cases were followed for recurrence from initial presentation through 31 December 2002.
RESULTS: After chart review of 322 possible cases, 71 new cases and 59 previously diagnosed active cases of ocular HSV were confirmed. This resulted in an incidence rate of 6.8 new cases/100,000 person-years (95% confidence interval, CI, 5.3-8.6). Incidence increased with age, and rates were highest in people over 75 years of age (p < 0.001). The recurrence rate in new cases was 18% for the 3-year follow-up time, and was equal to 5% per year (95% CI 3-9%).
CONCLUSION: The incidence and prevalence of ocular herpes simplex in this study was lower than previously reported. Incidence increased with age, and there were significantly higher rates in the older population.

Entities:  

Keywords:  Epidemiology; eye; herpes simplex virus; keratitis

Mesh:

Year:  2014        PMID: 25299934     DOI: 10.3109/09286586.2014.966848

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  8 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  [Corneal wound healing-Pathophysiology and principles].

Authors:  Tobias Brockmann; Marcus Walckling; Claudia Brockmann; Tho Mas A Fuchsluger; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-06-09       Impact factor: 1.059

Review 3.  Pathobiology and treatment of viral keratitis.

Authors:  Raghuram Koganti; Tejabhiram Yadavalli; Raza Ali Naqvi; Deepak Shukla; Afsar R Naqvi
Journal:  Exp Eye Res       Date:  2021-02-06       Impact factor: 3.467

4.  High-Risk Corneal Graft Rejection in the Setting of Previous Corneal Herpes Simplex Virus (HSV)-1 Infection.

Authors:  Lucia Kuffova; Jared E Knickelbein; Tian Yu; Carlos Medina; Guillermo Amescua; Alexander M Rowe; Robert L Hendricks; John V Forrester
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04       Impact factor: 4.799

Review 5.  The Role of T Cells in Herpes Stromal Keratitis.

Authors:  Naveen K Rajasagi; Barry T Rouse
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 6.  INCIDENCE OF HERPES SIMPLEX VIRUS KERATITIS AND OTHER OCULAR DISEASE: GLOBAL REVIEW AND ESTIMATES.

Authors:  Ian McCormick; Charlotte James; Nicky J Welton; Philippe Mayaud; Katherine M E Turner; Sami L Gottlieb; Allen Foster; Katharine J Looker
Journal:  Ophthalmic Epidemiol       Date:  2021-10-08

7.  Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology.

Authors:  Yike Jiang; Xiaotang Yin; Patrick M Stuart; David A Leib
Journal:  mBio       Date:  2015-10-27       Impact factor: 7.867

Review 8.  Adoption of Innovation in Herpes Simplex Virus Keratitis.

Authors:  James Chodosh; Lawson Ung
Journal:  Cornea       Date:  2020-11       Impact factor: 3.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.